Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spectrum: YCJ-01 for Refractory Epilepsy in TSC
NCT07403266Phase 3Recruiting
- Sponsor
- Oils4Cure
- Start
- Jun 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YCJ-01 in epilepsy, sponsored by Oils4Cure. Started Jun 2024; status: recruiting.
02
Drugs
YCJ-01
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07403266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07403266.